Table 8. Adverse Events related to Urinary System.

OD - Once Daily, BID - Twice Daily

Study	Urinary tract infection, n (%)
Goadsby et al.10
10 mg OD	2 (2)
30 mg OD	11 (6)
60 mg OD	5 (3)
30 mg BID	2 (2)
60 mg BID	3 (3)
Placebo	4 (2)
Ailani et al.13
10 mg OD	3 (1.4)
30 mg OD	9 (3.9)
60 mg OD	9 (3.9)
Placebo	8 (3.6)
Klein et al.16
60 mg OD	36 (5.3)
Ashina et al.17
60 mg OD	28 (5.2)